Molbank 2010, 2010(1), M661; doi:10.3390/M661
Short Note


Department of Drug and Natural Product Synthesis, Faculty of Life Sciences, University of Vienna, Althanstrasse 14, A-1090 Vienna, Austria
* Author to whom correspondence should be addressed.
Received: 9 February 2010; Accepted: 8 March 2010 / Published: 9 March 2010
PDF Full-text Download PDF Full-Text [97 KB, uploaded 9 March 2010 13:55 CET]
Abstract: The title compound was prepared by treatment of 1-(2-chlorophenyl)-3-methyl-2-pyrazolin-5-one with 2-chlorobenzoyl chloride / Ca(OH)2 in 1,4-dioxane and subsequent cyclization of the thus obtained 4-aroyl-5-hydroxypyrazole with sodium hydride in dry DMF. Detailed spectroscopic data (1H NMR, 13C NMR, 15N NMR, IR, MS) are presented.

Supplementary Files

Article Statistics

Load and display the download statistics.

Citations to this Article

Cite This Article

MDPI and ACS Style

Batezila, G.; Holzer, W. (2-Chlorophenyl)-3-methylchromeno[2,3-c]pyrazol-4(1H)-one. Molbank 2010, 2010, M661.

AMA Style

Batezila G, Holzer W. (2-Chlorophenyl)-3-methylchromeno[2,3-c]pyrazol-4(1H)-one. Molbank. 2010; 2010(1):M661.

Chicago/Turabian Style

Batezila, Giselle; Holzer, Wolfgang. 2010. "(2-Chlorophenyl)-3-methylchromeno[2,3-c]pyrazol-4(1H)-one." Molbank 2010, no. 1: M661.

Molbank EISSN 1422-8599 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert